BeStock  
Stocks › NRIX

Nurix Therapeutics NRIX

US equityMarket cap rank #2661Biotechnology
$22.88 −$0.11 (-0.48%)
Pre-market · Oct 6, 7:30 am ET · After hours $22.88 0.00%
Open$22.81
Prev close$22.99
Day range$22.43 – $23.31
Volume1.01M
Market cap$2.37B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-6.6x
CheapRich

Below its usual level · 24th percentile, 5-year average -5.5x

Price / book5.9x
CheapRich

Near the top of its 5-year range · 94th percentile, 5-year average 2.9x

#4452 of 5315 stocks by PB (1 = cheapest)

Price / sales64.6x
CheapRich

Near the top of its 5-year range · 95th percentile, 5-year average 20.4x

#4869 of 5147 stocks by PS (1 = cheapest)

P/E over five years

-21x-14x-7x0xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$23.22
Price vs. fair value-1.5%Close to the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 5.90 – 2.92 94% (pricier than usual) #4452 of 5315 (1 = cheapest)
PE -6.61 5.57 -5.46 24% (cheaper than usual) –
PS 64.58 3.06 20.41 95% (pricier than usual) #4869 of 5147 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$23.22
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on NRIX.

Leave a comment

Scroll to Top